Your browser doesn't support javascript.
loading
Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response.
Yu, Miao; Terhorst-Molawi, Dorothea; Altrichter, Sabine; Hawro, Tomasz; Chen, Yu-Di; Liu, Bo; Song, Xiao-Ting; Zhao, Zuo-Tao; Maurer, Marcus.
Affiliation
  • Yu M; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
  • Terhorst-Molawi D; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
  • Altrichter S; National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
  • Hawro T; Peking University School of Nursing, Beijing, China.
  • Chen YD; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Liu B; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Song XT; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Zhao ZT; Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Maurer M; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Clin Exp Allergy ; 51(5): 730-734, 2021 05.
Article in En | MEDLINE | ID: mdl-33522024
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab / Chronic Urticaria Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab / Chronic Urticaria Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Exp Allergy Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Affiliation country: China